STUDIES ON BACTERIOPHAGE : II. INHIBITION OF LYSIS OF ESCHERICHIA COLI B BY THE SOMATIC ANTIGEN OF PHASE II SHIGELLA SONNEI by Goebel, Walther F.
STUDIES  ON  BACTERIOPHAGE 
II.  INHIBITION  OF  LYSIS  OF  ESCHERICHIA COLI 13  BY  THE  SOMATIC 
ANTIGEN O~ PHASE II SHIGELLA SONNEI 
BY WALTHER  F. GOEBEL, Ps.D. 
(From the Laboratories of The Rockefeller Institute/or Medical Research) 
(Received for publication, July 18,  1950 
The characterization of substances which inhibit the multipfication of pneu- 
monia virus of mice and mumps virus (1) and the identification of those cellular 
constituents with which certain bacterial viruses combine immediately prior to 
infection of the host and subsequent viral mnltipfication (2) have been subjects 
of investigation in these laboratories during the past several years. In under- 
taking  the latter problem  the T  series  of bacteriophages and  the host  cells 
E. coli 13  (3) and Sh. sonnei Phase I  and II (4) were selected for study, first, 
because the viruses themselves have been so well characterized,  and,  second, 
because the antigenic structures of the two Sonne bacilli have been extensively 
investigated (5). 
Distributed on the cell surface of smooth variants of dysentery bacilli is a 
protein-lipocarbohydrate complex; it is this substance which differentiates one 
serological  type from the other,  conferring  upon the microorganism  its  type 
specificity (6). Although E. coli 13 is susceptible to each of seven of the T series 
of viruses  employed the  Sk.  sonnei  are  not;  the  Phase  I  microorganism  is 
attacked and lysed only by the T2 virus and T6, whereas the Phase II bacillus 
is susceptible not only to these two viruses, but to the "1"3, T~, and T~ as well. 
In the case of the Phase II bacillus there are grounds to believe that it is the 
surface antigen with which the T3, T4, and T7 viruses combine at the instant of 
infection,  for it has been found that in ~itro this material will inactivate all 
these  three  viruses and  render  them  incapable  of affecting young,  actively 
growing bacilli.  In the presence of appropriate cofactors, though not in their 
absence (7), this effect is produced by exceedingly small amounts of the protein- 
lipocarbo-hydrate complex.  In contrast, the T~ and Te viruses, which likewise 
attack Phase II Sh. sonnei,  are in no way affected by the agent, and for this 
reason it is assumed that these viruses attach themselves to receptor sites on 
the surface of the Phase II organism wholly different from the specific protein- 
lipocarbohydrate complex. 
In the following account it will be shown that E. coli 13 possesses an antigen 
serologically  related to the protein-lipocarbohydrate complex of Phase II Sh. 
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sonnei, and that lysis of E. coli B  by three of the T  viruses, T~, T~, and Tr, can 
be inhibited by the somatic antigen of the Phase II dysentery  bacillus.  It will 
algo be  seen  that  at  least  one of these viruses  is not a  homogeneous  popula- 
tion,  but  is  comprised  of particles  having  different  affinities  for  the  specific 
inhibitor  and,  in  addition,  contains  particles  some  of  which  are  capable  of 
infecting  both  Phase  II  Sh. sonnei and  E.  coli B,  and  others only the latter. 
Materials and Methods 
Somatic Antigens of Pka~e I  and H  Sk.  sonnei.--The  Phase I and H  somatic antigens of 
Sk. sonnei used in these experiments were obtained by methods previously described  (5). 
Sterile solutions of the antigens were prepared as follows: 10 rag. of substance was placed in a 
sterile test tube. The latter was flamed for most of its length and after cooling the antigen was 
wetted with 0.5 co. of 70 per cent alcohol. After standing for several hours 3.15 co. of sterile 
0.1 1  Na~HPO4 was added, and the tube warmed to 50°C. until solution of the antigen was 
complete. 1.35 cc. of 0.1 ~  K2HPO4 was now added and the solution was ready for use. 
Bacteriopkages.--The bacteriophages were obtained from Dr. Mark Adams of New York 
University as was the strain of E. coli B. Freshly prepared stocks of the phages were employed 
and were obtained by infecting actively growing aerated cultures of E. coti B in nutrient broth 
with the particular virus under investigation. All experiments described in this communica- 
tion were carried out in the latter medium except those with the T~ virus in which a meat in- 
fusion-neopeptone medium was used.  Fresh meat infusion appears  to contain a  cofactor of 
unknown nature which greatly enhances absorption of T~ on Phase H  Sk. sonnei. Viral assays 
were made by the technique of Hershey (8). 
Antisera.--Antibacterial sera were obtained from groups of rabbits injected with E. coli B 
and Sk. sonne/Phase II respectively. In addition, antisera to the chemically purified Phase II 
somatic antigen were likewise prepared as previously described (5). In all instances injections 
of the immunizing agent were given for 6 consecutive days followed by a rest period of 1 week 
and then a second series of injections was made. Bleedings were taken 8 days later. It has been 
observed in this laboratory that the sera of some normal rabbits even in high dilution aggluti- 
nate E. toll B (9). Before immunizing the animals it is essential to test them for the presence 
of such aggintinins, and to discard those animals which show positive reactions. Since cultures 
of Phase I  Sh. sonnei contain approximately 1 per cent of Phase II bacilli which are present 
because of spontaneous mutation (6), the sera of animals immunized with Phase I  organisms 
usually show a low agglutinating titer for Phase II bacilli. In order to have monovalent sera 
the Phase I sera were absorbed with heated or formal-killed suspensions  of Phase H organisms. 
Agglutination and Precipitin Reaclions.--In conducting the agglutination reactions it was 
found desirable to use in all instances as the aggintinogen 4 hour cultures of living organisms. 
The bacteria were washed once in nutrient broth before using.  Since cultures of E. coli B have 
a tendency to agglutinate spontaneously when diluted in saline, dilutions of the vaccines and 
sera were made in nutrient broth. The test mixtures were incubated at 37°C. for 2 hours, and 
the reactions read after the tubes had stood for 18 hours at 5°C. Precipitin reactions were 
carried  out in the conventional manner. When  quantitative  precipitin  reactions were per- 
formed, the phototurbidimetric technique described by Libby (10) was employed. 
Inkibition Tests.--Viral inhibition tests were performed as follows: The virus under investi- 
gation was diluted so as to contain approximately 2 X  10  s particles per co. Into each of four 
tubes was placed 0.5 cc. of a solution of inhibitor  1 at the appropriate concentration. The first 
1 It has recently been noted that different preparations of the specific antigen of Phase II 
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tube in the series contained 0.5 cc. of inhibitor (2 nag. per cc.) which had been  dissolved  in 
0.1 M  phosphate buffer at pH 7.2; all subsequent  dilutions (in increments of 10) were made in 
nutrient broth. A fifth tube served as a control, and contained 0.5 cc. of broth. 0.5 cc. of the 
virus dilution was added to each of the five tubes and the latter were incubated at 37°C. 
for 24 hours. 0.1 cc. of each inhibitor-virus mixture was plated, and plaque countsweremade 
after 12 hours of incubation. In several instances a second control was included in the experi- 
ment in which virus was diluted not with broth, but with 0.1 M  phosphate buffer (comparable 
to the first inhibition tube). The diluent made no difference, however, in the final plaque 
count. This test will also be referred to later as a test for the "resistance pattern" of a given 
virus. 
EXPF~  rMENTAL 
Agglutination Reactions of E. coli B  and Phase I  and II Sh. sonnei in Homol- 
ogous  and in 'Heterologous Antisera:--In  order to  study  the  serological  rela- 
TABLE  I 
Agglutination Reactions of Phase I and II Sh. sonnei  in E. cdi B Antiserum 
Final dilution  of antiserum 
Microorganism tested  ____ 
1.'200  1.'400  1:800  1:1600,  1:3200  [  1:6400  [  1:12.800 
[  I 
I  [  1--  -- 
Sh. sonnei Phase I  0  0  0  0  [  ]  [0  0  0 
....  Phase II  [  4  ]4  14  J  3  2  0  0 
4  =  complete agglutination, clear superuate. 
0  =  no agglutination. 
tionship between E. coli B  and Phase I  and II Sh. sonnei,  agglutination reac- 
tions of the three microorganisms in E. coli B  antiserum were first carried out. 
These  tests are recorded in Table I. It can be seen that Phase II Sh. sonnei 
is agglutinated by E. coli B  antiserum in high dilution, although the Phase I 
organism  is  not.  This  fact  indicates that  the  Phase  II bacillus possesses an 
antigen related to that on the surface of the colon bacillus. Further evidence 
in support of this is presented in Table II where it is seen that E. coli B  ag- 
glutinates in the sera of rabbits immunized with Phase II bacilli, as well as in 
an antiserum prepared by injecting animals with the purified and electrophor- 
etically homogeneous somatic antigen obtained from the Phase  II dysentery 
organism.  The  latter serum presumably contains antibodies directed against 
only the specific antigen of the Phase II bacillus and not toward other surface 
components of the microorganism. In view of the fact that E. coli B  is agglu- 
scure but the observation is being actively followed up. A single highly active preparation was 
used throughout the work reported here. Preparations of the Phase II somatic antigen, when 
kept in the dry state for periods as long as 15 months, have shown no diminution in their 
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tinated  by  this  antiserum,  it  seems  reasonable  to  conclude  that  the  colon 
bacillus possesses a  surface  antigen  closely related to  that  present  in Phase 
II Sh. sonnei. 
Still further  evidence is derived from  the fact  that  solutions of the  Phase 
II somatic antigen precipitate in E. coli B  antiserum (Table III). To be sure, 
the reaction is not as vigorous as that in homologous antiserum, yet precipita- 
tion occurs with reasonably high dilutions of the Phase II antigen. It is unfor- 
TABLE II 
Agglutination Reactions of E. coli B in Phase II Sh. sonnei Antibacterial and Somatic 
Antigen  Antisera 
Serum tested 
Phase II antibacterial 
Phase II antlsomatic anti- 
gen 
Microorganism 
tested 
Phase II 
E. coli B 
Phase II 
E. coU B 
1:100 
4 
4 
4 
3 
Final dilution of antiserum 
1:200  1:400  1:800  1:1600  1:3200 
4  4  4  3  2 
4  4  3  2  1 
4  4  4  3  2 
3  2  1  0  0 
1:6400 
TABLE III 
Precipitin Reactions of Pkase II Antigen in Homologous and in E. coli B Antibacterial 
Immune Sera 
Fins! dilution of test antigen 
Serum tested 
l: 10,000  1: 50,Oegl  l: 250,000  I: 1,250,000 
Phase II antisomatic antigen  ++++  ++-b:t:  ++  + 
E. coli B antibacterial  + +-4-  + +  +  O 
++++  =  disk-like precipitate, clear  supernate. 
tunate  that  a  reciprocal relationship  could  not  be  determined,  because  the 
surface antigen of E. coli B  has not yet been isolated. 
Agglutination  Reactions  of E.  coli B  and Sh.  sonnei  Phase II  in Phase II 
Antiserum  after  Absorption.--In  order  to  ascertain  whether  the  antigens  of 
E. coli B  and Phase II Sk. sonnei are identical or merely similar, absorption 
experiments were performed as follows.  ~-- 
3 cc. of a pooled serum of rabbits immunized with the chemically purified somatic antigen 
of the Phase II organism was diluted with 9 cc. of saline. To this was added the packed cells 
from the 3 cc. of a phenol-killed suspension of E. toll B containing 2 X  1011 bacilli per cc. 
Mter 2 hours incubation at 37°C. and 18 hours in the ice box, the bacilli were separated by 
centrifugation.  The process was repeated a second and finally a third time. The serum was 
then tested for its ability to agglutinate both Phase II bacilli and g. coli B. 
Since the immune serum originally contained antibodies directed only toward WALTHER  ~F.  GOEBEL  531 
the somatic antigen of the Phase II organism, absorption with E. coli B should 
remove agglutinins for both microorganisms if the antigens of Phase II and 
E. coli B are identical. If they are not, but are merely similar, then absorption 
with the heterologous organism should remove only those antibodies reactive 
with E. coli B, and leave those stiU specifically reactive with the homologous 
Phase II microorganism. 
It is apparent from Table IV that absorption of the immune serum with E. 
coli B removes only agglutinins for the latter microorganism and leaves those 
still specifically reactive with the Phase II hacmus. Absorption of the serum 
with the heterologous microorganism has apparently diminished but slightly 
its agglutinative power for the homologous Phase  II  bacillus.  Quantitative 
nephelometric precipitin measurements of the serum antibody reveal, however 
(Pig. 1) that some 30 per cent of the total antibody present in the original serum, 
TABLE IV 
Agglutination Reactions of Phase H  Sh. sonnel and E. coli B in Phase II Antigen Antiserum 
after Absorption with E.  ¢oli B 
Phase II antigen antiserum 
Unabsorbed 
Absorbed with E. coli B 
M;croorganism 
tested 
Phase II 
E. coli B 
Phase II 
E. coli B 
I:100 
4 
3 
Final dilution of serum 
1:200  1:400  1:800 
4  4 
2  1 
4  4 
0  0 
1:1600  1:320C  1:~0( 
and reactive with the homologous Phase II somatic antigen, was removed after 
absorption with E. coli B. 
To varying quantifies of a dilution (0.2 cc. of serum per ce.) of the original  and absorbed 
sera, and at constant volume  (1 cc.), was added 1 ec. of a solution  containing  50 micrograms  of 
Phase II antigen. The turbidity which developed was measured, and the results plotted as 
indicated in the accompanying  figure. 
The results of these experiments further substantiate the evidence already 
presented that the somatic antigen of Phase II Sit.  s~nei is related to, but 
not identical with, that found on the cell surface of E. coli B. In this respect 
the two antigens are analogous to the capsular polysaecharides of Types III 
and VIII pneumococcus (11). 
Inhibition of Lysis of E. coli B by the Somatic Antigen of Phase H  Sk. sonnei.--- 
It was previously pointed out that both Phase I  and Phase II Sk. sonnei are 
susceptible to certain of the T  bacteriophages and that lysis of the Phase II 
bacillus by T,, T~, and T~ is inhibited by small amounts of the  homologous 
bacterial antigen (2). It seemed of interest, particularly in view of the immun- 
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whether lysis of the colon bacillus by the T  phages could be inhibited by the 
dysentery antigens. 
The viral inhibition tests were performed as outlined above. In each instance varying 
quantities of the inhibitor were incubated with the virus under investigation for 24 hours 
before plating. Platings were made simultaneously on Phase II Sk. sonnei and on E. coli B. 
The plates were incubated 12 hours at 37°C. before counting the plaques. 
The results of these experiments are summarized in Table V where it can be 
seen that lysis of E.  coli B by Ts, T4, and T~ was indeed inhibited by the Phase 
II antigen, and that lysis of the organism by T~, T2, T6, and T6 was in no way 
affected. Although  data concerning  the  Phase  I  antigen  are not  included  in 
cr~ 
•  -~  60 
°5° 
20 
0.2  0.4  0.5  0.8 
Cc. o  T 5e~um  dilu%ion lested 
Fro.  1. Quantitative  precipitin reaction of Phase II antigen in homologous antiserum 
before and after absorption with E. coli B. 
I, serum before absorption with/~, coli B. 
2,  "  after  "  "  "  "  " 
the table it should be stated that this substance caused no significant inhibition 
of any of the viruses. The significance of these results will be discussed later. 
Susceptible  and Resistant  Variants  of T3.---It has been observed on occasions 
that certain stocks of Ts, "]?4, and T~ viruses, when stored at 5 ° C. over long 
periods of time, gradually lose their infectivity titers. In some instances these 
losses amount to as much as 3 log units. This change in titer is accompanied 
by a  diminution in the capacity of the virus to be inhibited by the Phase II 
somatic antigen. Thus, a  stock of T8 virus which had been kept for 8 months 
had dropped in titer from 1.2  X  10  ~° to 5  X  l0  T particles per co.  When  the 
resistance  pattern  of  the  original  virus  was determined  it  was found  to  be 
fully susceptible to the action of the inhibitor. Whereas  103, 10  ~, and 101 micro- 
grams of inhibitor inactivated in each instance 100, 99, and 65 per cent of the 
original virus, the aged virus showed 26,  7, and 0 per cent inactivation when 
tested with these same quantities of inhibitor. Similar observations were made 
on stocks of T4 and T~, though the decrease in susceptibility was not as striking. WALTHER  ~'.  GOEBEL  533 
In all instances the viruses could be restored  to  their original sensitivity by 
one or more passages on E. coli B in nutrient broth. 
Since Ta appears to be the least susceptible to the action of the inhibitor, 
this virus was chosen for study in order to ascertain whether it might not con- 
tain particles resistant to the action of the agent. That this proved to be the 
case will be seen from the following. 
To 1 cc. of the Ts stock containing 8 X  101°  particles per cc. was added 1 cc. of a solution 
containing 5 rag. of the Phase II somatic antigen. A control tube was likewise prepared con- 
taining 1 cc. of virus diluted with an equal volume of the same buffer as that used in preparing 
TABLE V 
Inhibition of Lysis of Phase II Sh. sonnei and E. coli B by the Somatic Antigen of Sh.sonnei 
Phase II 
Plating microorganism 
Sk. son~ Phase II 
E. coli  B 
Virus teated 
Ts 
T, 
Ts 
T, 
Ts 
Ts 
T7 
TI 
T, 
Ta 
T, 
I"6 
Ts 
T7 
~' of inhibitor* 
__  5 X  1___.___~ 
0 
0 
99 
100 
0 
0 
92 
0 
0 
91 
lid 
0 
0 
94 
101 
0 
0 
89 
0 
87 
0 
0 
78 
99 
0 
0 
90 
101  10o 
0  0 
0  0 
34  11 
97  74 
0  0 
0  0 
44  9 
0  0 
0  0 
22  6 
96  65 
0  0 
0  0 
50  6 
* The figures represent per cent of virus inactivated. 
the antigen solution. Both tubes were maintained at 37°C. and the virus concentrations de- 
termined in each at varying time intervals, using Phase II Sk. sonnd as the host cell. At the 
termination of the experiment the virus remaining in the tube containing the inhibitor was 
separated from the latter by centrifugation at 20,000 g for 1 hour. The virus was resuspended 
in 10 cc. of broth, again sedimented, and the washing repeated. The residual virus was now 
taken up in 2 cc. of broth and assayed (5 X 106). The resistance pattern of this virus, referred 
to in the accompanying table as TsRI, was then determined. The material was next divided 
into two equal portions. To one was added an equal volume of the inhibitor s6intion used 
above; the other, which served as a  control, was diluted with an equal volume of buffer. 
Again the decrease in virus concentration was followed at the indicated time intervals, and 
the resistance pattern of the remaining virus (T,Rs) likewise determined. 
The results of these experiments which are presented graphically in Fig. 2 
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that the rate of inactivation of the T3 virus is relatively slow. This is in con- 
trast to the observation  made on T4 which is rapidly inactivated by the Phase 
II antigen (2). Second, it will be observed that by no means all of the virus 
10  lj 
10  IC 
"~  10 9 
lo e 
10 7 
1o6! 
"----w------ 
-2 
'3 
I  l  I  I  I  I 
1  2  3  4  5  7 
Time in day~ 
Fro. 2.  Rate of inactivation of Ta by the somatic antigen of Phase II Sh. sonnei. 
1, T3 on standing in presence of 2.5 rag. per cc. of Phase II antigen. 
2, virus without inhibitor (controD. 
3, remaining Ta virus in presence of fresh inhibitor. 
4; virus without inhibitor (control). 
TABLE VI 
Resistance Pattern of T, and of the Residual Virus Remaining afar Inactivation 
by Phase I[ Antigen 
"r of inhibitor 
10  s 
10  ~ 
10 ~ 
100 
E. coli B 
Ratio Phase II 
Ts 
98 
89 
34 
11 
1.12 
Percentage virus inactivated 
TsRI 
55 
25 
0 
0 
TsR~ 
40.¸0 
Ta  =  original virus stock before treatment with specific inhibitor. 
TaR1  ffi residual virus after first treatment with specific inhibitor. 
TsR2 ffi residual virus after second treatment with specific inhibitor. 
was inactivated by the inhibitor. In a 72 hour period the titer of the virus had 
dropped from 8  X  101° to a  constant value of  1  X  l0  T. When the resistance 
pattern of this residual virus (T3R1) was determined (Table VI) approximately 
half of the viral particles were still found to be susceptible to the action of the 
inhibitor.  The addition  of new inhibitor  to  the  sedimented and  washed  virus WALTHER  ]~. GOEBEL  535 
brought about a decrease in titer of about one-half log unit. This residual virus 
(T3R~) was now entirely resistant to the action of the inhibitor as can be seen 
in Table VI. 
Thus it appears  that T3 consists of a  population of at least  two types of 
viral particles, those which combine with the specific inhibitor and are rendered 
incapable of infecting the host, and those which are unaffected even by high 
concentrations of the inhibitor and retain their ability to infect the Phase II 
microorganism.  These  two  types of virus  will  be  referred  to  as  susceptible 
and resistant.  They appear to coexist in normal stocks of T3 in the ratio  of 
approximately 104:1, respectively. It wiU be shown later that in stocks of Ta 
still another variant exists which is incapable of infecting Phase II Sit. sonnei. 
Is Resistance a Stable Characteristic?--If the property of resistance exhibited 
by the residual virus described above is  transmissible  to new generations of 
viral particles, it should be possible to demonstrate this in the virus of plaques 
arising from resistant particles. 
0.1  cc.  of a  dilution of the resistant virus TsR~ containing 2  X  l0  t  particles per cc. was 
plated with Phase II Sk. sonnei. After 12 hours' incubation, ten of the plaques, which appeared 
on the plate and varying  in size  from 2 to 0.5 ram., were removed  by means of a sterile glass eye- 
dropper of appropriate diameter and having a flue sharpened edge. The plaques, together 
with the agar beneath them, were each transferred to 5 cc. of sterile broth at 0°C. After stand- 
ing for 15 minutes the tubes were warmed to 37°C. for 7 minutes, again cooled to 0°C., and 
filtered in the cold to sterilize. The ten virus preparations were next assayed, then an aliquot 
diluted so as to contain 2 ×  108 particles per ec. An equal volume of a sterile solution of the 
specific inhibitor containing 0.2 rag. per cc. was now added to each of the ten viruses. The 
tubes, together with the proper controls, were incubated at 37°C. for 24 hours and then plated 
using Phase II Sk. sonnei as the host. One hundred micrograms of inhibitor per ec: appears to 
be the optimal minimum amount of inhibitor necessary to give complete inhibition of all 
susceptible particles. 
If the viruses obtained from the ten plaques had regained the property of 
susceptibility, the inhibition experiments performed at this one concentration of 
inhibitor should suffice to determine whether the newly generated viruses were 
resistant  or  susceptible.  Despite  the  fact that  the  ten  newly formed clones 
of  viral  particles  had  originated  from single  particles  which  were  resistant 
(assuming,  of course, that the particles themselves are not mixed aggregates), 
it can be seen from Table  VII that  the progeny had regained susceptibility. 
In each instance the viruses derived from the ten plaques were as susceptible 
to the action of the inhibitor as was the parent stock from which the resistant 
virus had been obtained. These experiments reveal that the property of resis- 
tance is not transmissible under the environmental conditions employed, and 
therefore it must be considered an unstable  characteristic. 
A second attempt was made to produce a  resistant stock of virus by infect- 
ing colon bacilli actively growing in broth containing 1 rag. per cc. of the specific 
inhibitor, with a suspension of the resistant viral particles. Under these  condi- 536  STUDIES  ON  BACTERIOPHAGE.  II 
tions it was thought that an environment unfavorable to the development  of 
the susceptible particles but favorable to the development of resistant variants 
would be furnished. 
3 cc. of nutrient broth containing 1 nag. of the Phase II antigen per cc. was inoculated with 
E. coli B. When growth had reached approximately 5 X  l0  T bacilli per cc. the tube was in- 
fected with a total of 3  X  los particles  of the resistant  virus T~R~ obtained  as described 
above.  After approximately  2 hours  of aeration  the tube had cleared. The contents  were 
filtered and the virus then placed at 37°C. and assayed at the end of 24, 48, and 72 hours. It 
was found that the titer diminished progressively from approximately 3 X  10  ~° particles to 
S X  l0  s particles in this time interval.  A determination  of the resistance pattern of the re- 
maining virus showed that some 65 per cent of the viral particles were still susceptible to the 
action of the specific inhibitor. Repetition of the experiment, using the residual virus, yielded 
essentially the same results. 
TABLE VII 
Susceptibility of Virus Isolated  from Ten Plaques Originatlngfrom Resistant Virus T3R2 
Virus from plaque No,  Per cent virus inhibited by 10~ of Phase II antigen 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
97 
94 
97 
95 
97 
98 
90 
96 
93 
93 
The  above experiment  is  further  demonstration  of the  fact  that  infection 
of a bacterial population with the resistant variant of Ta yields progeny which 
is predominantly  susceptible.  The  rapid  drop  in  titer  of the  virus  after  the 
final burst is due to gradual inactivation of newly formed susceptible particles 
by the inhibitor. The fact that the rate of inactivation is relatively slow makes 
it possible to observe this phenomenon. That the titer of the virus drops only 
approximately  2  log  units  and  leaves  a  population  containing  some  65  per 
cent of susceptible particles, is to be explained on the basis that the concentra- 
tion of inhibitor is simply not sufficient to bring about complete inactivation 
of all susceptible particles. Two successive passages of the virus in the presence 
of inhibitor were made.  Each time the virus was permitted  to stand first for 
72 hours at 37°C. before infecting new host cells. Each time the virus was passed, 
the newly formed virus showed on standing the same relative drop in titer as did 
the virus of the first passage. Although the environment was deemed favorable 
for the development of resistant virus, still it was not possible to obtain by this 
means a  stock containing a  preponderance  of the resistant variant. WALTHER  ]L  GOEBEL  537 
A  Variant of T3 Specific for E. coli B.--If one assays a freshly prepared stock 
of T3 on Phase II Sh. sonnei and at the same time on E. coli B, it will be noticed 
that a slightly higher count is obtained on plates infected with the latter micro- 
organism. If enough plates are counted to be of significance, it is found  that 
there  are approximately 5  to  10  per  cent  more  plaques  on  those plates for 
which the colon bacillus served as the host cell. If one now makes a  differential 
count  of the residual T3 virus described above  (i.e.,  of the virus which is no 
longer inhibitable by the Phase  II antigen)  it is found  that  the  ratio of the 
number  of plaques formed on  Phase  II to  those appearing on E.  coli  B  has 
increased from  1:1.12  to 1:40  (see Table VI). The original T3 stock, in addi- 
tion to containing a  variant resistant to inhibition by the Phase  II antigen, 
TABLE VIII 
Assay of Virus  Isolated from Six Plaques Originating from an E. coli B  Specific 
Variant  of Ta 
Plaque No. 
I 
II 
III 
IV 
V 
VI 
T3* (control) 
E.  coliB 
Average plaque couut when plated on 
Phase II 
101 
116 
101 
105 
105 
114 
210 
57 
78 
59 
69 
73 
74 
188 
E. coli B 
Ratio  -- 
Phase II 
1.79 
1.49 
1.71 
1.52 
1.44 
1.54 
1.12 
* Original T8 stock before treatment with specific inhibitor. 
yet capable of infecting this cell, appears to contain still another variant. The 
latter is not inactivated by further addition of the Phase II antigen, and appears 
to be capable of infecting only E. coli B. 
The so called resistant virus T3R2 was diluted so that on the average only one plaque was 
formed when 0.1 cc. of the dilution was plated with Phase II Sh. sonnei. When plated with E. 
coli B, this same dilution yielded an average of 41 plaques. Six of these plaques were now iso- 
lated and the virus recovered as described above. Each virus stock was assayed on E. coli B, 
then diluted to contain 1 X  103 particles per cc. 0.1 cc. of each dilution was now plated on 
Phase II Sh. sonnei and on E. coli B using four plates in each instance.  After 12 hours' incu- 
bation the plaques were counted and the results tabulated (Table VIII). Since the resistant 
virus had been so diluted that the probability of selecting a plaque arising from a viral par- 
tide infective only for E. coli B, and not for Phase II Sh. sonnei, was 40:1, the chance was 
sl/ght that one of the six plaques selected would be reactive with both organisms. 
The results presented in Table VIII indicate quite clearly that transmission 
of the property of specificity for E. coli B, under the environmental conditions 
selected,  cannot  be  achieved.  The  clone of viral particles in  the  six plaques 538  STUDIES  ON  BACTERIOPHAGE.  II 
under investigation probably all arose from individual viral particles capable 
of infecting only E. coli B. Yet the new viral population in each instance con- 
sisted of particles capable of infecting both those cells and they occurred es- 
sentially in the same ratio as that in the virus stock from which the so called 
resistant virus had originally been prepared. In this respect the second variant 
shows unstable characteristics similar to those noted above. 
DISCUSSION 
When a susceptible bacteriophage is brought into contact with a sufficiently 
high concentration of a  specific inhibitor, the two substances appear to inter- 
act and the virus is rendered incapable of infecting the host from which the 
inhibitor was derived. The  nature of the chemical union between inhibitor 
and phage is not understood, nor is it yet known whether the virus itself is 
irreparably altered. Furthermore, it has not yet been ascertained whether in- 
fectious virus can be released from the inactive complex. Although the mechan- 
ism of its action is obscure, the fact remains that the somatic antigen of Phase 
II Sh. sonnei can specifically inactivate in vitro three of the T  viruses, T3, T4, 
and TT. It has been suggested therefore that this substance, distributed on the 
surface of the dysentery bacillus, serves as the receptor for the phages in ques- 
tion at the instant of inception of the infectious process. From immunological 
evidence presented in this communication it has been shown that an antigen 
similar to that of Phase II Sh. sonnei is present on the cell surface of E. coli B, 
and it is suggested that this antigen serves in a similar capacity when the colon 
bacillus undergoes infection with T3, T4, or TT." 
That the two microorganisms possess a  similar surface antigen is substan- 
tiated by the fact that the colon bacillus agglutinates in an antiserum to the 
chemically purified dysentery antigen, and by the fact that the latter is pre- 
cipitated by an antiserum to the colon bacillus. These antigens are not identical, 
however, for some, but not all, of the antibodies are removed from Phase II 
antigen immune serum by absorption with E. coli B. Since the two antigens 
show immunological crossing they must likewise be related chemically. It is 
reasonable to think, therefore, that these two substances can function similarly 
as receptors for the same viruses. The isolation of the new antigen from E. 
coli B has not been undertaken. It cannot be said therefore whether it is a single 
chemical entity, or a part of a  more complex molecule which has affinity for 
others of the T  series of viruses. 
There are many examples among antigen-antibody reactions for which it has 
been shown that part but not all of the antibody protein combines with an 
heterologous antigen. One example was reported from this laboratory many 
years ago (12). It was shown that the native capsular polysaccharide of Type 
I pneumococcus possesses  a labile acetyl group. When the latter was removed, 
the resulting deacetylated polysaccharide was  still  capable  of reacting with 
Type I antibody. When sera were absorbed with the deacetylated polysaccha- WALTHER  1  ~.  GOEBEL  539 
ride, a  residue of antibody remained which failed to react with the chemically 
altered carbohydrate but was still reactive with the native polysacchaxide. It 
is  conceivable that  the  isolated antigen of Phase  II Sh.  sonnei  has  suffered 
alteration during its chemical purification. As finally isolated it may no longer 
represent an exact replica of the  bacterial antigen as it occurs in its native 
state  and  hence  cannot  carry  to  completion the  inactivation of all the T3 
viral particles in a  given population. 
Assuming  this  to be  so,  one might  anticipate finding  in  a  virus-inhibitor 
mixture only residual particles capable of infecting both host cells,  Phase II 
Sh. sonnei and E. coli B. This is not the case, however, for it has been seen that 
the  partially  inhibited  residual  virus  TsR1  is  but  slightly affected by fresh 
bacterial antigen. The decrease in titer which takes place is slight and equals 
the residual susceptible viral particles. The virus which remains, T~R2, is no 
longer affected by the specific inhibitor. Moreover, it contains a variant having 
a  specificity different from that of the majority of the original viral particles. 
Thus it has been shown that stocks of T~, after treatment with the inhibitor, 
contain at least two variants,  neither of which is inhibited by further treat- 
ment with the Phase II antigen. One of these combines with and infects both 
the Phase II dysentery bacillus and E. coli B; the other infects only the latter 
microorganism.  This fact suggests  the  hypothesis that  both microorganisms 
possess  still other receptors through which  these variants,  and  indeed other 
viruses, as well, can combine and bring about the infectious process. The nature 
of these receptors is not yet known. 
Those who have studied the inhibition of phages by extracts of microorgan- 
isms (13)  and by specific antisera (14) have come to the conclusion that  viral 
populations are probably not homogeneous but may contain a small proportion 
of particles which are relatively resistant to these agents. Several investigators 
have demonstrated that the property of resistance cannot be transmitted  to 
new generations of viral particles. In certain respects the action of the  Phase 
II antigen of Sh.  sonnei  on the T, virus is comparable to that of a  specific 
antiserum. When virus and inhibitor are mixed the majority of particles  are 
rendered incapable of infecting the host cell but a small portion remains which 
is resistant  to the inhibitor.  In the case of the resistant virus T3R1 and  the 
residual virus T3R2, which exhibits specificity only for g. coli B, it cannot be 
said whether these variants arise as a  result of the action of the specific in- 
hibitor  on  normal  virus  particles,  or  whether  they  are  naturally  occurring 
phenotypic variants. One fact seems to be clear, however, and that is neither 
of these properties appears  to be  transmissible  to  new  generations of virus 
particles. 
During the course of this investigation the author has discussed it often with Dr. 
Frank L. Horsfall, Jr., and with Dr. Ruth Sager. He wishes to express his appreciation 
for their interest and for their many stimulating suggestions. 540  STUDIES  ON  BACTERIOPHAGE.  IX 
SUMM.ARY 
By serological means it has been shown that E. coli B contains an antigen 
closely related to the protein-lipocarbohydrate  complex of Phase II Sh. sonnei. 
Lysis of E. coli B by three of the T viruses, T3, T4, and Tv, can be inhibited by 
the Phase II dysentery antigen.  It has been  suggested  that the receptor of 
E. coli  B with which these viruses combine is this newly described antigenic 
component.  Two variants of the virus T3 have also been described,  in stocks 
which have been treated with the Phase II antigen. One of these variants in- 
fects both Phase II Sh.  sonnei and E. coli  B, and the other infects  only the 
latter microorganism; neither of the two variants is inhibited by concentrations 
of the Phase II antigen of 1 rag. per cc. The distinctive properties  of the vari- 
ants are not hereditary. WALTHER  3~. GOEBEL  541 
APPENDIX 
A Bacteriophage Plaque and Colony Counter 
(IN CO~A~OV.A~ON WITH MR. JOS~-VH BLm~) 
The counting of plaques can become a chore of no mean dimension in bacteriophage 
research. In this laboratory we have occasion to count as many as a  100 plates daily 
A~ 
,  8 ~  I!:i 
I 
To~  Yle~ 
Section A-A 
FIo. 3.  Petri dish adapter. 
I 
4~  u  ~A 
13/; 
and mechanical assistance in the execution of this task is essential The conventional 
Quebec counter is helpful, and the addition of an electrically  operated counting device 
described by Varney (15)  is a decided improvement. Unfortunately this equipment is 
no longer available commercially nor to our knowledge is any other mechanical device 
for counting bacterial colonies. A simple apparatus has therefore been devised which 
has been of great assistance in counting accurately and rapidly bacteriophage plaques. 
A 4  X 5 inch DeJur professional model photographic enlarger, having the light and 542  STUDIES  ON  BACTERIOPHAGE.  II 
condenser  housing  separated  from  the bellows,  was  fitted with  a  sliding bakelite 
adapter built to carry two Petri dishes (Fig. 3). A  150 watt bulb served as the light 
source and an F  4.5 anastigmatic lens was fitted to the lens board. An dectrical im- 
pulse reset counter manufactured by the Production Instrument Company, Chicago, 
model EC-94, was mounted adjacent to the enlarger post at an angle of 45 °. An elec- 
trical contact switch in the form of an aluminum pencil holder in which a  soft lead 
~ 
llO volt line 
:ts, on phosphor bronze ! 
duralumin  tublng 
old pencil 
FIG. 4.  Electric switch pencil holder. 
pencil was inserted was wired in series with the counter and was operated from the 
110 volt A.C. circuit (Fig. 4). When the tip of the pencil is touched to the paper, con- 
tact is made within the switch and the impulse is registered in the counter. The Petri 
dish without its lid, is inserted face downward in the adapter. The image of the dish, 
magnified two and one-half fold, is projected on a  sheet of paper placed on the en- 
larger easel board. The images of the plaques can be counted either by touching indi- 
vidually, or by streaking five at once. A plate with 100 plaques can be counted in less 
than a minute. WALTHER F.  GOEBEL  543 
If the Petri dish holder is constructed to hold the dish without its lid and with the 
agar half facing the lens, an image is had which extends to the very edge of the dish. 
Thus it is possible to see all the plaques on the agar surface except those which, be- 
cause of the pouring technique,  have crept to the perpendicular edge. If the pouring 
is carefully done, there will be few plaques in this position, and any error introduced 
by plaques which are not visible is small. This can of course be corrected by counting 
the latter in the conventional manner. This equipment can also be used to count bac- 
terial colonies, to examine the morphology of phage plaques and bacterial colonies as 
well. Permanent negative records can be made by projecting the image on sensitized 
paper and developing the latter. 
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